Oncology, answered.

ISPOR Europe

November 8 - 11, 2026

Vienna, Austria

Booth # 1018

7 research acceptances

Request a meeting

Unlock critical evidence to accelerate global oncology access

Answer your toughest oncology questions with real-world evidence. Our multinational data spans the US, UK, Germany, and Japan, backed by a decade of strategic partnerships with regulators and HTAs. We deliver evidence that researchers, payers, and regulators trust.

Featured speaking session

Setting the global standard: What it takes to scale AI-curated oncology data across countries

Date: Tuesday, November, 10, 2026 | 3:15 - 3:45pm | Exhibit Hall

As AI-curated oncology data expands across countries and disease areas, how can researchers ensure the data remains accurate, consistent, and clinically meaningful? Join clinical and scientific experts from Flatiron Health to discover our approach to transparent data validation and how it is used in practice across the US and international markets to maintain a high standard for real-world data at global scale.

View session

Arun Sujenthiran, MD

Clinical Lead and Senior Medical Director, International

Flatiron Health

Connect on LinkedIn

Qianyi Zhang, MS

Director, Research Sciences

Flatiron Health

Connect on LinkedIn

Experience Flatiron’s new global Panoramic datasets

Visit our booth to experience our global data live in Flatiron Telescope, our AI-powered intelligence platform.

Book a live demo

Flatiron Networking Reception at Hotel Sacher Vienna

Monday, November 9

19:30 - 22:30 CET

Join us for an evening of networking, cocktails and hors d'oeuvres at our exclusive networking reception. RSVP is required.

RSVP now

Flatiron Health expands Telescope to international real-world data for more than 6 million patients

Life sciences teams can now explore patient populations, assess study feasibility, and generate insights across the US, UK, Germany, and Japan

Read press release

Preview our research at ISPOR Europe

Our acceptances highlight how real-world data, clinical expertise, and analytics come together to answer complex oncology questions spanning multinational real-world evidence, Panoramic dataset validation, and transportability.

Meet with us

Posters

Key Considerations for Synthesizing Cross-Country Oncology RWE Transportability Studies

Author affiliations: Flatiron Health, Flatiron Health Germany, Flatiron Health UK, Roche, UMIT TIROL - University for Health Sciences and Technology

Poster Session: Poster Session 1
Poster Code: SA8
Poster Session Date/Time: Monday, 9 November, 10:30-13:30
Discussion Period: 12:30-13:30

Benchmarking as a Tool for Assessing Cross-Country Comparability of Survival Evidence for HTA

Author affiliations: Flatiron Health, Flatiron Health UK

Poster Session: Poster Session 1
Poster Code: HTA28
Poster Session Date/Time: Monday, 9 November, 10:30-13:30
Discussion Period: 12:30-13:30

Comparison of Patient Characteristics and First-Line Treatment Patterns in Metastatic NSCLC: US and Finland Cohorts to Inform Overall Survival Transportability Analyses

Author affiliations: Roche, Flatiron Health, Medaffcon, Helsinki University Hospital

Poster Session: Poster Session 2
Poster Code: SA30
Poster Session Date/Time: Monday, 9 November, 16:00-19:00
Discussion Period: 18:00-19:00

Controlling for What Comes Next: Estimating Generalized Direct Effects of First-line Therapy on Real-world Overall Survival Using Counterfactual Second-line Distributions in Advanced Non-small Cell Lung Cancer

Author affiliations: Flatiron Health

Poster Session: Poster Session 4
Poster Code: MSR200
Poster Session Date/Time: Tuesday, 10 November, 16:00-19:00
Discussion Period: 18:00-19:00

Extending the Validation of Accuracy for Large Language Model (LLM)–/Machine Learning (ML)–Extracted Information and Data (VALID) Framework Globally: Quality Assessment of LLM-Derived Prostate Cancer Real-World Data in the UK

Author affiliations: Flatiron Health UK, Flatiron Health Germany, Flatiron Health

Poster Session: Poster Session 5
Poster Code: MSR263
Poster Session Date/Time: Wednesday, 11 November, 9:00-11:30
Discussion Period: 9:00-10:00

Real-World First-Line Treatment (tx) Patterns in Androgen Receptor Pathway Inhibitor (ARPI)-Experienced Metastatic Castration-Resistant Prostate Cancer (mCRPC) by Race/Ethnicity and Area-Level Socioeconomic Status (SES) in the US

Author affiliations: Case Western Reserve University, Pfizer, Flatiron Health, Huntsman Cancer Institute

Poster Session: Poster Session 1
Poster Code: HSD15
Poster Session Date/Time: Monday, 9 November, 10:30-13:30
Discussion Period: 12:30-13:30

Cross-Country Differences in Real-World Laboratory Monitoring Intensity and Hepatotoxicity Adverse Event Detection Among Initiators of CDK4/6 Inhibitors for Advanced Breast Cancer

Author affiliations: Flatiron Health

Poster Session: Poster Session 5
Poster Code: RWD173
Poster Session Date/Time: Wednesday, 11 November, 9:00-11:30
Discussion Period: 9:00-10:00